title: Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations.
authors.affiliation: Department of Transplantation and Hepatobiliary Diseases, Lahey Clinic Medical Center, Burlington, MA 01805, USA. elizabeth.a.pomfret@lahey.org
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Pomfret
authors.forename: J Peter A
authors.initials: JP
authors.lastname: Lodge
authors.forename: Federico G
authors.initials: FG
authors.lastname: Villamil
authors.forename: Mark
authors.initials: M
authors.lastname: Siegler
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D046148:Donor Selection / Q000941:ethics*; D019317:Evidence-Based Medicine; D006305:Health Status Indicators; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects / Q000941:ethics* / Q000401:mortality; D019520:Living Donors / Q000941:ethics*; D018579:Patient Selection / Q000941:ethics*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D057212:Therapeutic Equipoise